[Skip to Content]
[Skip to Content Landing]

Conference Commentary: Extracorporeal Membrane Oxygenation (ECMO) for Severe Acute Respiratory Distress Syndrome (ARDS) and Posterior Probability of Mortality Benefit in a Post Hoc Bayesian Analysis of a Randomized Clinical Trial

Alain Mercat, MD, of the University of Angers, France, comments on the findings of a post hoc Bayesian Analysis of the EOLIA trial, which compared the effects on mortality of venovenous extracorporeal membrane oxygenation (ECMO) vs conventional mechanical ventilation on outcomes for patients with severe acute respiratory distress syndrome (ARDS). Comments were made at the European Society for Intensive Care Medicine (ESICM) 31st Annual Congress, LIVES 2018, on October 22 in Paris. Used with permission.

JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 CME Credit™ from articles, audio, Clinical Challenges and more. Learn more about CME/MOC

CME Disclosure Statement: Unless noted, all individuals in control of content reported no relevant financial relationships. If applicable, all relevant financial relationships have been mitigated.

Close

Name Your Search

Save Search
Close
Close

Lookup An Activity

or

Close

My Saved Searches

You currently have no searches saved.

Close

My Saved Courses

You currently have no courses saved.

Close
Close